Introduction to a Special Issue of the Journal of Immunological Methods: Building Global Resource Programs to Support HIV/AIDS Clinical Trial Studies
Abstract
This Special Issue of the Journal of Immunological Methods includes 16 manuscripts
describing quality assurance activities related to virologic and immunologic monitoring
of six global laboratory resource programs that support international HIV/AIDS clinical
trial studies: Collaboration for AIDS Vaccine Discovery (CAVD); Center for HIV/AIDS
Vaccine Immunology (CHAVI); External Quality Assurance Program Oversight Laboratory
(EQAPOL); HIV Vaccine Trial Network (HVTN); International AIDS Vaccine Initiative
(IAVI); and Immunology Quality Assessment (IQA). The reports from these programs address
the many components required to develop comprehensive quality control activities and
subsequent quality assurance programs for immune monitoring in global clinical trials
including: all aspects of processing, storing, and quality assessment of PBMC preparations
used ubiquitously in HIV clinical trials, the development and optimization of assays
for CD8 HIV responses and HIV neutralization, a comprehensive global HIV virus repository,
and reports on the development and execution of novel external proficiency testing
programs for immunophenotyping, intracellular cytokine staining, ELISPOT and luminex
based cytokine measurements. In addition, there are articles describing the implementation
of Good Clinical Laboratory Practices (GCLP) in a large quality assurance laboratory,
the development of statistical methods specific for external proficiency testing assessment,
a discussion on the ability to set objective thresholds for measuring rare events
by flow cytometry, and finally, a manuscript which addresses a framework for the structured
reporting of T cell immune function based assays. It is anticipated that this series
of manuscripts covering a wide range of quality assurance activities associated with
the conduct of global clinical trials will provide a resource for individuals and
programs involved in improving the harmonization, standardization, accuracy, and sensitivity
of virologic and immunologic testing. © 2014 Elsevier B.V.
Type
Journal articlePermalink
https://hdl.handle.net/10161/22002Published Version (Please cite this version)
10.1016/j.jim.2014.05.016Publication Info
Sanchez, AM; Denny, TN; & O'Gorman, M (2014). Introduction to a Special Issue of the Journal of Immunological Methods: Building
Global Resource Programs to Support HIV/AIDS Clinical Trial Studies. Journal of Immunological Methods, 409. pp. 1-5. 10.1016/j.jim.2014.05.016. Retrieved from https://hdl.handle.net/10161/22002.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Thomas Norton Denny
Professor in Medicine
Thomas N. Denny, MSc, M.Phil, is the Chief Operating Officer of the Duke Human Vaccine
Institute (DHVI), Associate Dean for Duke Research and Discovery @RTP, and a Professor
of Medicine in the Department of Medicine at Duke University Medical Center. He is
also an Affiliate Member of the Duke Global Health Institute. Previously, he served
on the Health Sector Advisory Council of the Duke University Fuquay School of Business.
Prior to joining Duke, he was an Associate Professor of Pathology, Labo

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info